@FierceBiotech: ICYMI yesterday: Celgene bags a build-to-buy biotech in $485M cancer deal. Report | Follow @FierceBiotech
@JohnCFierce: Biogen CEO Scangos commits $2.5B to a high stakes Alzheimer's gamble. More | Follow @JohnCFierce
> Sanofi's ($SNY) Genzyme business scored the FDA's fast-track designation for GZ/SAR402671, a Phase II treatment for the rare Fabry disease. More
> PTC Therapeutics ($PTCT) kicked off a Phase I study for PTC596, an oral cancer treatment targeting the protein BMI1. News
> Cerulean Pharma ($CERU) picked up a fast-track nod for CRLX101, a nanoparticle-drug conjugate designed to treat renal cancer in combination with Roche's ($RHHBY) Avastin. Item
Medical Device News
@FierceMedDev: ICYMI yesterday: Two U.S. hospitals to test startup's novel medical device malware detection software. Article | Follow @FierceMedDev
@VarunSaxena2: FDA bans manufacturing of Medtronic's infusion pump, citing violation of quality system regs. News | Follow @VarunSaxena2
@EmilyWFierce: Scanadu ropes in $35M for smartphone tricorder diagnostic device. More | Follow @EmilyWFierce
> Belgian molecular Dx player Biocartis raises €100M to advance recent launch of Idylla system. Story
> 'Stealthy' Medina raises $6M in debt for cerebral aneurysm device after CE mark last fall. Article
Pharma News
@FiercePharma: Daiichi Sankyo has solid chance to pare debt, reinvest on Sun stake sale, Moody's says. More from FiercePharmaAsia | Follow @FiercePharma
@EricPFierce: Bayer to close a vet med plant in Missouri it bought from Teva. 130 workers to lose jobs. More from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: Would any of you guys want to read a special report entitled "The secret first initials of biopharma CEOs and what they stand for"...? | Follow @CarlyHFierce
> Flush with Q1 success, Merck touts coming launches in hep C, lung cancer. Story
> It's official: Takeda to pay a 'bargain' $2.3B to settle Actos lawsuits. Article
Drug Delivery News
> Presage's multiple-cancer-drug injection device shows promising first-in-human results. Story
> Topical gel for migraine shows promise in trials, can penetrate transdermal barrier. Item
> 3M says its new intravenous port dressing will make drug delivery easier and fight off site infections. Report
> AbbVie's FDA-approved Duopa gel for Parkinson's skates through yearlong study. Story
> Generex announces second medical marijuana outlicensing deal for its drug delivery tech. Article
Pharma Manufacturing News
> Texas cancer center guilty of selling foreign-made Avastin. Item
> Wockhardt recalling all pre-ban products still in the U.S. More
> Mylan recalls injected cancer meds made for Pfizer. Story
> GSK licks Nicorette manufacturing problems; 'Minis' are back. Article
> Lilly's Elanco to unload former Novartis vax plant. News
Pharma Asia News
> Eisai, Nihon Medi-Physics plan work on dementia with Lewy bodies. Report
> India mulls adopting international standards on drug inspections, manufacturing. Story
> Cipla leans toward compromise in India court case over Onbrez from Novartis. More
> Japan's Panasonic joins Toshiba in rush to medical devices. Article
> Daiichi Sankyo has solid chance to pare debt, reinvest on Sun stake sale, Moody's says. Item